{"id":1490,"date":"2019-05-20T22:09:12","date_gmt":"2019-05-20T22:09:12","guid":{"rendered":"https:\/\/www.medicalmarijuanainc.com\/?p=216352"},"modified":"2019-05-20T22:09:12","modified_gmt":"2019-05-20T22:09:12","slug":"axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/","title":{"rendered":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment"},"content":{"rendered":"

Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines.<\/span><\/i><\/h3>\n

Leading cannabinoid research and new drug development company AXIM\u00ae Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). <\/span><\/p>\n

The provisional patent application is for a patent on a chewing gum composition comprising of cannabinoids and parthenolide (feverfew extract) for treatment of symptoms of <\/span>migraines<\/span><\/a>. This provisional application establishes AXIM\u00ae\u2019s filing date for the patent and gives AXIM\u00ae one year to file a formal patent application for their invention.<\/span><\/p>\n

AXIM\u00ae Biotechnologies has already built a strong intellectual property portfolio with 5 issued patents, 12 pending patents, and 28 trademarks. The company is looking to expand on this IP portfolio with additional new drugs and consumer products formulated with cannabinoids, including this cannabinoid-based treatment for migraine symptoms. <\/span><\/p>\n

The company is currently in development or trials for cannabinoid chewing gum treatments for \u00a0symptoms related to multiple sclerosis, chemotherapy, AIDS, drug-related psychosis, and restless leg syndrome, with more on the way.<\/span><\/p>\n

\u201cAXIM is best known for its patent on chewing gum containing cannabinoids and our flagship CBD chewing gum product, CanChew+,\u201d said AXIM CEO John W. Huemoeller II.\u201cWith this patent application and AXIM\u2019s current cannabis chewing gum products currently in development, we plan to bring a variety of treatment options to the market.\u201d<\/span><\/p>\n

With this new provisional patent application, AXIM\u00ae plans to develop a cannabinoid chewing gum that contains cannabidiol (CBD) and\/or cannabigerol (CBG), as well as feverfew extract, for the treatment of symptoms that often accompany migraines, such as headache, pain, nausea, and light sensitivity. <\/span><\/p>\n

Feverfew has been proven to relieve and prevent symptoms of migraines. The company is looking to combine these effects with the benefits of cannabinoids like CBD and CBG for a novel way for migraine sufferers to find quick relief. <\/span><\/p>\n

The new formulation will be delivered through AXIM\u00ae\u2019s proprietary sustained-release chewing gum delivery technology to release active ingredients in a controlled manner into the oral cavity for a fast but lasting onset of effects.<\/span><\/p>\n

There is currently no permanent cure for migraines, so treatments are aimed at relief of symptoms. The market for migraine treatments has been growing as global incidence has increased. According to Grand View Research, Inc., the global migraine treatment market size is expected to reach <\/span>$7.8 billion by 2025<\/span><\/a>. Although the migraine market is highly competitive, many migraine sufferers are looking for alternative treatments like CBD that don\u2019t feature that harsh synthetic chemicals found in most current treatment options. <\/span><\/p>\n

\u201cAs a company of firsts, Medical Marijuana, Inc. is proud to support AXIM as it files this patent application for the first-ever cannabis-based gum formulated to treat the symptoms of migraines,\u201d said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \u201cStudies have estimated that migraines affect roughly 38 million people in the U.S. and the market currently lacks an effective natural treatment option for those people.\u201d<\/span><\/p>\n

You can learn more about AXIM\u00ae Biotechnologies, including its latest new drug developments, <\/span>here<\/span><\/a>, or visit our <\/span>news feed<\/span><\/a> for the latest from across our portfolio of companies. <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM\u00ae Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). The provisional patent application is for a patent on […]<\/p>\n","protected":false},"author":1,"featured_media":1491,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3],"tags":[],"class_list":["post-1490","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news"],"yoast_head":"\nAXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM\u00ae Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). The provisional patent application is for a patent on […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-20T22:09:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2019\/05\/iStock-504377120.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment\",\"datePublished\":\"2019-05-20T22:09:12+00:00\",\"dateModified\":\"2019-05-20T22:09:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\"},\"wordCount\":525,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"articleSection\":[\"Axim Biotechnologies\",\"Company News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\",\"name\":\"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2019-05-20T22:09:12+00:00\",\"dateModified\":\"2019-05-20T22:09:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/","og_locale":"en_US","og_type":"article","og_title":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.","og_description":"Medical Marijuana, Inc. investment AXIM\u00ae Biotechnologies looks to expand impressive intellectual property portfolio with patent on cannabinoid chewing gum for migraines. Leading cannabinoid research and new drug development company AXIM\u00ae Biotechnologies recently filed a provisional patent application with the United States Patent and Trademark Office (USPTO). The provisional patent application is for a patent on […]","og_url":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2019-05-20T22:09:12+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2019\/05\/iStock-504377120.jpg","type":"image\/jpeg"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment","datePublished":"2019-05-20T22:09:12+00:00","dateModified":"2019-05-20T22:09:12+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/"},"wordCount":525,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"articleSection":["Axim Biotechnologies","Company News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/","url":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/","name":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2019-05-20T22:09:12+00:00","dateModified":"2019-05-20T22:09:12+00:00","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2019\/05\/20\/axim-biotechnologies-takes-steps-toward-patenting-cbd-based-migraine-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"AXIM\u00ae Biotechnologies Takes Steps Toward Patenting CBD-Based Migraine Treatment"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/1490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=1490"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/1490\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/1491"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=1490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=1490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=1490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}